Product Description: ML3403 is a potent p38 MAPK inhibitor with an IC50 of 0.38 μM[1].
Applications: COVID-19-immunoregulation
Formula: C23H21FN4S
References: [1]Kammerer B, et al. Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor. Drug Metab Dispos. 2007 Jun;35(6):875-83.